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 2 
Abstract 26 
Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy has 27 
been used to investigate the effects of three fatty acid esters on skin permeation. 28 
Propylene glycol diperlargonate (DPPG), isopropyl myristate (IPM) and isostearyl 29 
isostearate (ISIS) were selected as pharmaceutically relevant solvents with a range 30 
of lipophilicities and cyanophenol (CNP) was used as a model drug. The resultant 31 
data were compared with that obtained when water was used as the solvent. The 32 
diffusion of CNP, DPPG and IPM across epidermis were successfully described by a 33 
Fickian model. When ISIS was used as a solvent Fickian behaviour was only 34 
obtained across isolated stratum corneum suggesting that the hydrophilic layers of 35 
the epidermis interfere with the permeation of the hydrophobic ISIS. The diffusion 36 
coefficients of CNP across epidermis in the different solvents were not significantly 37 
different. Using chemometric data analysis diffusion profiles for the solvents were 38 
deconvoluted from that of the skin and modelled. Each of these solvents was found 39 
to diffuse at a faster rate across the skin than CNP. DPPG considerably increased 40 
the concentration of CNP in the stratum corneum in comparison with the other 41 
solvents indicating strong penetration enhancer potential. In contrast IPM produced a 42 
similar CNP concentration in the stratum corneum to water with ISIS resulting in a 43 
lower CNP concentration suggesting negligible enhancement and penetration 44 
retardation effects for these two solvents respectively. 45 
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Introduction 51 
The stratum corneum, the outermost layer of skin is the main barrier to the 52 
absorption of drug molecules across and into human skin. This barrier has important 53 
implications for the topical treatment of skin conditions as it may render a particular 54 
treatment ineffective. Modification of the barrier properties of the stratum corneum is 55 
often sought primarily to increase drug penetration and the use of chemical 56 
penetration enhancers in a formulation is perhaps the most common strategy used to 57 
achieve this. A variety of different types of molecules have been shown to have the 58 
potential to affect drug permeation including alcohols, esters and fatty acids 59 
(Gorukanti et al., 1999; Liu et al., 2009; Ogiso et al., 1995). These molecules modify 60 
the properties of the stratum corneum altering drug flux across the skin. However it is 61 
difficult to elucidate the mechanisms through which they exert their actions. 62 
Improved knowledge of how individual enhancers modify skin penetration would 63 
facilitate formulation design and perhaps also give insight into how combinations of 64 
enhancers can have synergistic effects greatly increasing skin penetration 65 
(Goldbergcettina et al., 1995), allowing this effect to be utilised in formulations.  66 
 67 
Fatty acid esters have been commonly used as penetration enhancers, with IPM 68 
being the most commonly used (Goldbergcettina et al., 1995; Gorukanti et al., 1999; 69 
Kikwai et al., 2002; Leichtnam et al., 2006; Liu et al., 2006; Yamato et al., 2009). 70 
Other examples of such molecules which have been investigated for this effect 71 
include ethyl oleate, decyl oleate, propylene glycol laurate, propylene glycol 72 
monolaurate, propylene glycol monocaprylate/caprate, glyceryl 73 
monocaprylate/caprate and ISIS (Cornwell et al., 1998; Gwak and Chun, 2002; 74 
Kikwai et al., 2002; Liu et al., 2006; Ozawa et al., 1988; Takahashi et al., 1996). 75 
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These molecules exhibit considerable variation in their physiochemical properties, 76 
differing in hydrocarbon chain length, number of hydrocarbon chains and polarity. 77 
The effect of these molecules as chemical penetration modifiers of drug transport is 78 
however variable. For example IPM as a sole agent may increase drug permeation 79 
significantly (Gorukanti et al., 1999) but the effect may be modest in other cases and 80 
some of the other esters such as propylene glycol laurate and glyceryl 81 
monocaprylate/caprate have been demonstrated to be superior to IPM for particular 82 
drug molecules (Cornwell et al., 1998; Gwak and Chun, 2002). Also in combination 83 
with other enhancers these esterified solvents have shown a synergistic penetration 84 
enhancement effect, though this is not always the case (Alberti et al., 2001; 85 
Gorukanti et al., 1999; Gwak and Chun, 2002; Liu et al., 2009). Better insight into the 86 
mechanism of action of these types of enhancers would facilitate their selection and 87 
help rationalise the topical formulation development process.          88 
 89 
Diffusion across a membrane may be followed using ATR-FTIR spectroscopy which 90 
potentially offers improved mechanistic insight into the role of penetration enhancers 91 
on drug diffusion than can be gained with conventional in vitro diffusion experiments 92 
such as those performed using Franz cells. The technique makes it easier to 93 
separate the effect of the enhancer on the concentration and diffusion coefficient of 94 
the drug in the stratum corneum and can also give molecular insight into the 95 
mechanism of action. For example Harrison et al have correlated the increase in the 96 
diffusion coefficient of a model compound, cyanophenol across the stratum corneum 97 
with increased fluidity of the intercellular lipids (Harrison et al., 1996). The technique 98 
also allows the diffusion profile of the enhancer to be monitored and can give insight 99 
into drug transport mechanisms. Tantishaiyakul et al used ATR-FTIR spectroscopy 100 
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to follow the diffusion of ion pairs and McAuley et al have reported the diffusion of 101 
hydrogen bonded species across model membranes (McAuley et al., 2009; 102 
Tantishaiyakul et al., 2004). 103 
 104 
In this study the effect of three fatty acid ester solvents on the transport of a model 105 
drug CNP across human epidermis have been investigated using ATR-FTIR 106 
spectroscopy. The esters examined, IPM, ISIS and DPPG are all used in topical 107 
formulations and have a range of polarities and hence should provide insight into the 108 
effects of these types of enhancers on drug transport across human skin.            109 
 110 
Materials 111 
CNP was obtained from Fisher Scientific (Loughborough, UK). IPM was obtained 112 
from Sigma-Aldrich (Poole, UK). ISIS was received as a gift from Uniqema (Gouda, 113 
The Netherlands) and DPPG was received as a gift from Gattefosse (Saint-Priest, 114 
France).  115 
 116 
Methods 117 
 118 
Tissue preparation 119 
Dermatomed human thigh skin from a single female patient was obtained from the 120 
International Institute for the Advancement of Medicine. Separated epidermis was 121 
prepared by blunt dissection following heat separation. The dermatomed skin was 122 
defrosted for two hours at room temperature before being immersed in a water bath 123 
at 60°C for 1 minute. The tissue was then pinned to a cork board and the epidermis 124 
was peeled away from the dermis using tweezers. Isolated stratum corneum was 125 
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prepared by soaking the epidermis in phosphate buffered saline containing 0.0001% 126 
trypsin for 24 hours at 37°C (Pellett et al., 1997b). The stratum corneum was then 127 
rinsed thoroughly with deionised water. All skin tissue was stored frozen at -20°C 128 
and allowed to thaw at room temperature prior to use. 129 
 130 
ATR-FTIR spectroscopy studies 131 
Diffusion experiments were conducted at ambient temperature (21 ± 2 ºC) using a 132 
Nicolet Avatar 360 FTIR spectrometer fitted with a multibounce ATR accessory with 133 
a Zinc Selenide (ZnSe) crystal. The incident angle of the IR radiation was 45°.  Ten 134 
scans were taken every 60 seconds with resolution of 2 cm-1 and an average 135 
spectrum was produced at each time point. All experiments were repeated in 136 
triplicate. Spectral analysis was performed using Opus® 5.5 software.  137 
 138 
Epidermis was placed on the ZnSe crystal so that the stratum corneum was in direct 139 
contact with the crystal. Intimate contact between the epidermis and crystal was 140 
assessed visually. This type of experimental set up using epidermis for ATR-FTIR 141 
spectroscopic studies of diffusion has been described previously (Tetteh et al., 142 
2009).   An aluminium trough constructed specifically for the diffusion experiments 143 
was placed on top of the epidermis and was sealed with silicone grease. A saturated 144 
CNP solution was applied to the membrane and an aluminium lid was placed on top, 145 
again sealed with silicone grease.  146 
 147 
When isolated stratum corneum was used it was placed on the ZnSe crystal so that 148 
the outer surface was in direct contact with the crystal, thus the stratum corneum 149 
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was placed on the ATR crystal in the same orientation as in the epidermis 150 
experiment.   151 
 152 
Saturated solutions of CNP in the three esters were prepared by constant agitation 153 
of excess of CNP in the solvent in the presence of an immiscible water layer for 48 154 
hours. The aqueous layer was then removed prior to the solution being used. The 155 
CNP solutions were equilibrated with water to prevent them from dehydrating the 156 
skin tissue and causing it to curl off the ATR crystal. The saturated solution of CNP 157 
in water was prepared by constant agitation of an excess of CNP in water for 48 158 
hours.  159 
 160 
Data modelling 161 
Assuming that the Beer-Lambert law applies, the increase in IR absorbance 162 
associated with either the drug or solvent molecule with time is directly related to the 163 
concentration of the species in the membrane. The increase in absorbance can 164 
therefore be modelled by fitting appropriate boundary conditions to Fick’s second 165 
law, 166 
 167 
         Equation 1 168 
 169 
 170 
where C is the concentration of the diffusing species in the membrane, D is the 171 
diffusion coefficient of the diffusing species, x is the diffusional pathlength, and t is 172 
time. In this study the method of Laplace transformation was used to solve Equation 173 
1 to obtain diffusion coefficients for the permeating molecules across skin. This 174 
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approach has been reported previously (McAuley et al., 2010).  The diffusion 175 
coefficients were obtained by fitting the normalised data with Micromath Scientist® 176 
3.0 for Windows, using the following Laplace transformation; 177 
 178 
         Equation 2 179 
 180 
 181 
where A  is the absorbance, A  is the absorbance at infinite time, C  is the 182 
concentration in the Laplace domain, C  is the concentration in the Laplace domain 183 
at infinite time, s is the Laplace variable and h is the diffusional pathlength. Statistical 184 
analyses were made using Graphpad Prism 5 software. Comparisons of the 185 
calculated diffusion coefficients were made using the Kruskal Wallis test with post 186 
hoc comparison made using the Mann-Whitney U test. Significance was accepted at 187 
the p < 0.05 level.    188 
 189 
Solubility studies 190 
The solubilities of CNP at 21 ± 2°C in water, IPM, DPPG and ISIS were measured by 191 
UV absorbance at 249nm. Saturated solutions of the model drugs were prepared 192 
using constant agitation for 48 hours. An aliquot of this was then centrifuged to 193 
separate any solid material and the supernatant was sampled, diluted as necessary 194 
and analysed. 195 
 196 
 197 
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Chemometric data analysis was used to obtain the diffusion profiles of the solvents. 200 
The multivariate target factor analysis approach was used to deconvolute the solvent 201 
profile from that of the skin and CNP. The analysis was conducted using InSight 202 
(InSight 4.0a, 2009) software coded in Matlab® (Matlab, R2009a). The algorithms 203 
and methods used by this programme are described in more detail elsewhere (Dias 204 
et al., 2004). 205 
   206 
Results 207 
Figure 1 shows IR spectra taken at different time points following application of CNP 208 
in DPPG to human epidermis. The increase in the CN stretch of CNP at 2227 cm-1 209 
can clearly be seen as can that associated with the carbonyl band of DPPG at 1742 210 
cm-1. The Amide I and II bands of the stratum corneum are also identifiable 211 
confirming good contact between the epidermis and crystal throughout the 212 
experiment. 213 
 214 
The CN stretching absorption band of CNP occurs in a spectrally silent skin region 215 
that also does not overlap with absorption bands associated with the solvents used 216 
in this study. Assuming the Beer-Lambert law applies the absorbance of this band 217 
can be directly related to the concentration of CNP in the stratum corneum and 218 
through monitoring the change in absorbance with time a diffusion profile of CNP 219 
across the membrane can be obtained. Figure 2 shows diffusion profiles of CNP in 220 
the different solvents used in this study across human epidermis.  221 
 222 
Typical Fickian plots were observed for the diffusion of CNP in DPPG, water and 223 
IPM across epidermis with the expected lag, exponential and plateau phases (Pellett 224 
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et al., 1997a). The diffusion traces of CNP in IPM and water are similar whereas the 225 
plateau absorbance of CNP in DPPG is much greater, indicating that a higher 226 
concentration of CNP is obtained in the stratum corneum when DPPG is the vehicle. 227 
The CNP in ISIS diffusion experiment again shows the typical lag and exponential 228 
diffusion phases, however the plateau absorbance appears to slowly decrease rather 229 
than maintain an equilibrium value. This slowly decreasing plateau was observed to 230 
correspond to the permeation of ISIS into the membrane. Figure 3 shows two 231 
spectra taken from the CNP in ISIS diffusion experiment and shows a decrease in 232 
the magnitude in the CN stretch, indicating a lower CNP concentration in the stratum 233 
corneum with increasing ISIS permeation into the membrane as observed through a 234 
stronger carbonyl absorption which is associated with the solvent. 235 
 236 
 237 
From the ATR-FTIR spectra the diffusion profiles of the different solvents used in the 238 
study can be obtained. The solvents, IPM, ISIS and DPPG all have an ester carbonyl 239 
group which absorbs in a region where the absorption of skin components is 240 
relatively weak (see Figure 1). However this functional group is often involved in 241 
hydrogen bonding, which alters the frequency of absorption and may affect the 242 
absorption coefficient limiting the usefulness of this band for diffusion profile 243 
analysis. Indeed CNP is known to hydrogen bond to these types of solvents 244 
(McAuley et al., 2009). Instead a chemometric approach has been used to 245 
deconvolute the spectral signal of the solvent from that of the other components in 246 
the 1478-1350cm-1 wavenumber window which is not believed to change with 247 
interactions between the molecules. Figure 4 shows the separation of the spectral 248 
profiles associated with DPPG and the stratum corneum extracted by the InSight 249 
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software and the corresponding evolution of each signal with time. Typical Fickian 250 
profiles were observed for the three solvents but ISIS had a significantly longer lag 251 
time than either DPPG or IPM. These diffusion profiles for CNP, IPM and DPPG 252 
could be modelled using Scientist to obtain a diffusion coefficient for the permeating 253 
species. Figure 5 shows example normalised diffusion profiles and model fittings for 254 
CNP and IPM across epidermis following application of a saturated solution of CNP 255 
in IPM. The profiles are normalised by setting the plateau value in each case (C∞) to 256 
1 enabling presentation on the same scale. The calculated diffusion coefficients are 257 
given in Table 1. These are reported as pathlength normalised values (D/h2) as the 258 
diffusional pathlength across the stratum corneum is unknown. Table 1 also provides 259 
the equilibrium solubility results for CNP in each of the solvents and the plateau 260 
absorbance values for each of the diffusion experiments. Model fitting of the ISIS 261 
diffusion profile obtained using epidermal tissue was less successful however as the 262 
lag time was observed to be overly long in comparison with the exponential phase. 263 
To investigate whether the more hydrophilic layers of epidermis were affecting the 264 
permeation of ISIS into the stratum corneum the CNP in ISIS experiment was 265 
repeated using stratum corneum prepared from the same skin tissue. Using isolated 266 
stratum corneum typical Fickian diffusion plots were observed for both CNP and ISIS 267 
allowing diffusion coefficients to be calculated, again shown in Table 1. For 268 
comparative purposes the diffusion of CNP across epidermis and stratum corneum 269 
from an ISIS vehicle are shown in Figure 6. The experiment across stratum corneum 270 
has a lower plateau absorbance than that obtained across epidermis but remains 271 
constant as is expected if the diffusion follows Fick’s law rather than the slowly 272 
decreasing value obtained in the CNP across epidermis experiment. 273 
 274 
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 275 
The ingress of ISIS into the stratum corneum appears to lower the concentration of 276 
CNP in the stratum corneum to less than that produced when water is the vehicle. In 277 
this case ISIS would be expected to act as a penetration retarder. This data 278 
suggests that the hydrophilic layers in the epidermis affect the ingress of the 279 
hydrophobic ISIS into the stratum corneum in the epidermal tissue experimental 280 
design and that for excipients such as ISIS, use of stratum corneum is preferable. 281 
 282 
 283 
 284 
Table 1. The solubility of CNP in each solvent, the plateau absorbance of CNP in the 285 
stratum corneum and the calculated diffusion coefficient for CNP (mean values ± the 286 
range, n=3). ND not determined.  287 
 288 
Solvent 
CNP solubility 
(mol/dm
3
) 
Plateau absorbance 
CNP D/h
2
                       
(x 10
-5 
s
-1
) 
Solvent D/h
2
 (x 
10
-5 
s
-1
) 
Dipropylene glycol perlargonate 1.185 6.31 (6.09-6.55) 9.4 (9.0-9.9) 17.7 (11.5-27.2) 
Isopropyl myristate 0.681 3.51 (2.86 4.00) 7.3 (6.9-7.8) 21.1 (9.0-27.2) 
Isostearyl isostearate 0.387 1.93 (1.55 – 2.53) 13.8 (11.7-15.8) 28.8 (27.2-30.4) 
Water 0.123 3.26 (2.85 - 3.82) 10.3 ( 9.4 – 11.2)        ND 
 289 
 290 
Discussion 291 
Since the initial publications using ATR-FTIR spectroscopy to investigate drug 292 
diffusion across skin in the mid 1990s, only a few studies have been published using 293 
skin tissue. This is likely to be a result of difficulties in performing the experiment 294 
using stratum corneum. Mounting the stratum corneum onto the ATR crystal is 295 
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difficult as the tissue is fragile and is readily damaged or torn. In this study we have 296 
reported using human epidermis instead of isolated stratum corneum for ATR-FTIR 297 
spectroscopic studies across skin. The skin is positioned such that the stratum 298 
corneum is in direct contact with the ATR crystal. This ensures that the data obtained 299 
from the experiment relates to the concentration of the permeants in the stratum 300 
corneum. Using epidermal tissue allows reliable, reproducible contact to be made 301 
between the membrane and the ATR crystal. Such an experiment design studying 302 
diffusion across human epidermis has been reported using an ATR-FTIR 303 
spectroscopic imaging setup (Tetteh et al., 2009). Pellet et al have previously 304 
investigated the effect of stratum corneum orientation on the ATR crystal with 305 
permeability and did find some differences depending on whether the inner or outer 306 
surface of the stratum corneum was placed on the ATR crystal (Pellett et al., 1997b). 307 
However it is thought that this is unlikely to affect interpretation of data in a 308 
consistent experimental design where relative differences between formulations are 309 
being used to gauge the effects of excipients to promote transport across skin.   310 
 311 
Typical Fickian diffusion profiles were obtained for the permeation of CNP across the 312 
epidermis which allowed it to be modelled, enabling calculation of the diffusion 313 
coefficients of CNP in the different vehicles and assessment of the effects of the 314 
vehicle on the concentration of CNP in the stratum corneum. The plateau 315 
absorbance value obtained during the permeation experiment relates to the 316 
concentration of CNP in the membrane. Solvents capable of increasing the 317 
concentration of the CNP in the stratum corneum are likely to act as penetration 318 
enhancers (Moser et al., 2001). DPPG was found to produce much higher 319 
concentrations of CNP in the membrane than the other solvents. This is likely to be a 320 
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feature of both the good solubility of CNP in DPPG and the significant uptake of the 321 
solvent into the stratum corneum, which was observed through the increase in the 322 
absorbance of the solvent’s carbonyl band during the experiment. The data indicates 323 
that DPPG is likely to act as a strong penetration enhancer for CNP( and presumably 324 
other structurally similar molecules) across skin. In contrast CNP in IPM showed a 325 
similar plateau absorbance to that of CNP in water, suggesting limited enhancing 326 
potential through altering the concentration of CNP in stratum corneum. This result 327 
agrees with previous findings which reported the ability of IPM to act as an enhancer 328 
as a single solvent for particular drugs to be modest (Kikwai et al., 2002). In the CNP 329 
in ISIS experiment using epidermal sheet, ISIS appeared to reduce the concentration 330 
of CNP in the slowly, such that the diffusion profile did not come to an equilibrium 331 
plateau absorbance over the timescale of the experiment. The slowly decreasing 332 
plateau absorbance of the CN stretch was observed to correspond to the permeation 333 
of ISIS into the membrane and analysis of the solvent diffusion profile suggested that 334 
it was non Fickian indicating that ISIS was behaving differently to the other solvents. 335 
To investigate this further the CNP in ISIS experiment was repeated using stratum 336 
corneum prepared from the same piece of skin tissue and placed on the ATR crystal 337 
in the same orientation as it is in the epidermis experiment. This allowed 338 
investigation of whether the inner, more hydrophilic epidermal layers may have 339 
impeded the permeation of ISIS into the stratum corneum, preventing the effects of 340 
the solvent on CNP diffusion into the skin from being readily apparent. The resultant 341 
data produced typical Fickian diffusion plots for the CNP diffusion across stratum 342 
corneum, with an equilibrium plateau absorbance lower than that obtained when 343 
water is the solvent, indicating that ISIS lowers the concentration of CNP in the 344 
stratum corneum. The data indicate that whilst use of human epidermis appears to 345 
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be valid for the use of DPPG and IPM with the more hydrophobic solvents such as 346 
ISIS the presence of the more hydrophilic epidermal layers will affect the observed 347 
diffusion profiles of permeating species and that in these circumstances, stratum 348 
corneum should be used. That ISIS lowers the concentration of CNP in the stratum 349 
corneum suggests that it acts as a penetration retarder. This is despite the solubility 350 
of CNP in ISIS being approximately three times larger than that of CNP in water and 351 
significant absorption of ISIS into the stratum corneum. This may be a result of the 352 
hydrophobic ISIS providing a less favourable environment than the endogenous 353 
lipids of the stratum corneum. There are cases where retardation of skin permeation 354 
is beneficial, typically when a drug or active is being targeted to the skin surface. 355 
Examples can include sunscreens and topical anti-microbials where a penetration 356 
retarder may prevent systemic exposure to the drug and thereby reduce toxicity 357 
(Hadgraft et al., 1996). ISIS may be a useful excipient for such formulations.  358 
 359 
The diffusion coefficients of CNP in DPPG, IPM and water across epidermis were 360 
similar. CNP in ISIS across stratum corneum did diffuse faster than those systems 361 
which were tested across epidermis as would be expected given that the lower 362 
epidermal layers will provide some diffusional resistance. However this difference is 363 
small which is consistent with the stratum corneum being the main barrier to the 364 
ingress of substances across skin (Hadgraft and Lane, 2011). The calculated 365 
diffusion coefficients are of a similar magnitude to those calculated by Pellett et al for 366 
the diffusion of CNP in water across stratum corneum (Pellett et al., 1997b). Thus 367 
the data suggest that the solvents tested do not enhance skin permeation by 368 
decreasing the membranes diffusional resistance, though it may be possible that 369 
pre-treatment of the skin with a solvent is necessary to fully elucidate the effects on 370 
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the diffusion coefficient in this type of experimental set up. Chemometric analysis 371 
software (InSight) was used to extract diffusion profiles of the ester solvents across 372 
the skin tissue. A spectral region was chosen where issues such as hydrogen 373 
bonding between the CNP and the solvent would not interfere with the observed 374 
diffusion profile. The diffusion profiles of DPPG and IPM across epidermis and ISIS 375 
across stratum corneum were obtained and could be modelled to obtain diffusion 376 
coefficients.  Each of the fatty acid ester solvents was found to diffuse at a faster rate 377 
than the CNP. Previous ATR-FTIR spectroscopic diffusion studies across silicone 378 
membrane found that CNP diffused more quickly across that membrane than ISIS 379 
and that this seemed to correlate well with the increased molecular size of the ISIS 380 
molecule (McAuley et al., 2009). This was not observed in this study for diffusion 381 
across human tissue but potentially be explained through consideration of the 382 
functional groups of the molecules. Drug diffusion across skin has been inversely 383 
correlated to the number of hydrogen bonding groups on a molecule, with strong 384 
hydrogen bonding groups such as hydroxyl groups slowing diffusion to a greater 385 
extent that for example a carbonyl group(Pugh et al., 1996; Roberts et al., 1996). 386 
This effect is particularly strong when the number of hydrogen bonding groups on the 387 
molecule is small. Thus the presence of both hydroxyl and the hydrogen bond 388 
accepting nitrile groups on CNP may explain its slower diffusion across skin in 389 
comparison to the esterified solvents.     390 
 391 
 392 
 393 
 394 
Conclusions 395 
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ATR-FTIR spectroscopy has been used to study the diffusion of CNP across human 396 
epidermis in three separate fatty acid ester solvents and water. The diffusion of CNP 397 
in water, DPPG and IPM across human epidermis were modelled using Fick’s 398 
second law. In the case of CNP in ISIS, Fickian diffusion profiles were only obtained 399 
when stratum corneum was used. No significant differences were observed between 400 
the diffusion coefficients of CNP in the different vehicles across epidermis. CNP in 401 
ISIS diffused more quickly across stratum corneum though this difference was small 402 
and is probably linked to the removal of the lower hydrophilic epidermal layers. Using 403 
chemometric software, diffusion profiles of the fatty acid ester solvents were 404 
extracted and each of the esterified solvents was found to diffuse at a faster rate 405 
across skin tissue than the model drug. DPPG was found to be able to increase the 406 
concentration of CNP in the stratum corneum suggesting that it possesses strong 407 
penetration enhancing potential. IPM appeared to have a limited or negligible ability 408 
to enhance CNP permeation whereas, in contrast ISIS is able to lower the CNP 409 
concentration obtained in the stratum corneum suggesting that it has a penetration 410 
retarding effect.  411 
 412 
 413 
 414 
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Table 1. The solubility of CNP in each solvent, the plateau absorbance of 
CNP in the stratum corneum and the calculated diffusion coefficient for CNP 
(mean values ± the range, n=3). ND not determined.  
 
Solvent 
CNP solubility 
(mol/dm
3
) 
Plateau absorbance 
CNP D/h
2
                       
(x 10
-5 
s
-1
) 
Solvent D/h
2
 (x 
10
-5 
s
-1
) 
Dipropylene glycol perlargonate 1.185 6.31 (6.09-6.55) 9.4 (9.0-9.9) 17.7 (11.5-27.2) 
Isopropyl myristate 0.681 3.51 (2.86 4.00) 7.3 (6.9-7.8) 21.1 (9.0-27.2) 
Isostearyl isostearate 0.387 1.93 (1.55 – 2.53) 13.8 (11.7-15.8) 28.8 (27.2-30.4) 
Water 0.123 3.26 (2.85 - 3.82) 10.3 ( 9.4 – 11.2)        ND 
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Figure 1. ATR-FTIR spectra, taken as a function of time of a CNP in DPPG across 
epidermis experiment.  
Figure 2. Increase in CN peak absorbance with time of CNP in DPPG, IPM, ISIS and 
water across human epidermis. Error bars show the range (n=3). 
Figure 3. Decrease in CN stretch absorbance with increasing ISIS penetration into 
skin. Dashed line spectrum taken at 280 minutes, solid line spectrum taken at 620 
minutes  
Figure 4. Deconvoluted spectrum of the DPPG signal (A1) from that of the stratum 
corneum (B1) in the 1478-1350 cm-1 spectral window. Plots on the right hand side 
(A2 and B2) show the corresponding evolution profiles with time. 
Figure 5. Typical normalised absorbance plots showing the diffusion of CNP and IPM 
across human epidermis with associated model fittings. 
Figure 6. Increase in CN peak absorbance with time of CNP in ISIS across human 
epidermis and human stratum corneum. Error bars show the range (n=3). 
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